Literature DB >> 20000552

Organic chemistry and biology: chemical biology through the eyes of collaboration.

Victor J Hruby1.   

Abstract

From a scientific perspective, efforts to understand biology including what constitutes health and disease has become a chemical problem. However, chemists and biologists "see" the problems of understanding biology from different perspectives, and this has retarded progress in solving the problems especially as they relate to health and disease. This suggests that close collaboration between chemists and biologists is not only necessary but essential for progress in both the biology and chemistry that will provide solutions to the global questions of biology. This perspective has directed my scientific efforts for the past 45 years, and in this overview I provide my perspective of how the applications of synthetic chemistry, structural design, and numerous other chemical principles have intersected in my collaborations with biologists to provide new tools, new science, and new insights that were only made possible and fruitful by these collaborations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20000552      PMCID: PMC3041175          DOI: 10.1021/jo901767e

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  148 in total

1.  A new type of synthetic peptide library for identifying ligand-binding activity.

Authors:  K S Lam; S E Salmon; E M Hersh; V J Hruby; W M Kazmierski; R J Knapp
Journal:  Nature       Date:  1991-11-07       Impact factor: 49.962

2.  Antagonist activity of the cyclic somatostatin analogue CTP at mu- but not delta- and kappa-opioid receptors involved in presynaptic inhibition of neurotransmitter release.

Authors:  A H Mulder; G Wardeh; W Kazmierski; V J Hruby
Journal:  Eur J Pharmacol       Date:  1988-11-15       Impact factor: 4.432

3.  Rational design of highly diastereoselective, organic base-catalyzed, room-temperature Michael addition reactions.

Authors:  V A Soloshonok; C Cai; V J Hruby; L Van Meervelt; T Yamazaki
Journal:  J Org Chem       Date:  2000-10-06       Impact factor: 4.354

4.  Expression-driven reverse engineering of targeted imaging and therapeutic agents.

Authors:  Robert J Gillies; Victor J Hruby
Journal:  Expert Opin Ther Targets       Date:  2003-04       Impact factor: 6.902

5.  Melanotropic peptide receptors: membrane markers of human melanoma cells.

Authors:  J Jiang; S D Sharma; J L Fink; M E Hadley; V J Hruby
Journal:  Exp Dermatol       Date:  1996-12       Impact factor: 3.960

6.  Effect of an alpha-melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction.

Authors:  H Wessells; D Gralnek; R Dorr; V J Hruby; M E Hadley; N Levine
Journal:  Urology       Date:  2000-10-01       Impact factor: 2.649

7.  Calcium-dependent prolonged effects on melanophores of [4-norleucine, 7-D-phenylalanine]-alpha-melanotropin.

Authors:  M E Hadley; B Anderson; C B Heward; T K Sawyer; V J Hruby
Journal:  Science       Date:  1981-08-28       Impact factor: 47.728

8.  MT-II induces penile erection via brain and spinal mechanisms.

Authors:  Hunter Wessells; Victor J Hruby; John Hackett; Guoxia Han; Preeti Balse-Srinivasan; Todd W Vanderah
Journal:  Ann N Y Acad Sci       Date:  2003-06       Impact factor: 5.691

9.  Melanophore stimulating hormone: release inhibition by ring structures of neurohypophysial hormones.

Authors:  V J Hruby; C W Smith; A Bower; M E Hadley
Journal:  Science       Date:  1972-06-23       Impact factor: 47.728

10.  4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity.

Authors:  T K Sawyer; P J Sanfilippo; V J Hruby; M H Engel; C B Heward; J B Burnett; M E Hadley
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

View more
  12 in total

1.  Time for cooperation in health economics among the modelling community.

Authors:  Renée J G Arnold; Sean Ekins
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

Review 2.  Natural products as sources of new drugs over the 30 years from 1981 to 2010.

Authors:  David J Newman; Gordon M Cragg
Journal:  J Nat Prod       Date:  2012-02-08       Impact factor: 4.050

3.  Potent and selective inhibition of a single alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor subunit by an RNA aptamer.

Authors:  Jae-Seon Park; Congzhou Wang; Yan Han; Zhen Huang; Li Niu
Journal:  J Biol Chem       Date:  2011-03-14       Impact factor: 5.157

4.  Design of novel neurokinin 1 receptor antagonists based on conformationally constrained aromatic amino acids and discovery of a potent chimeric opioid agonist-neurokinin 1 receptor antagonist.

Authors:  Steven Ballet; Debby Feytens; Koen Buysse; Nga N Chung; Carole Lemieux; Suneeta Tumati; Attila Keresztes; Joost Van Duppen; Josephine Lai; Eva Varga; Frank Porreca; Peter W Schiller; Jozef Vanden Broeck; Dirk Tourwé
Journal:  J Med Chem       Date:  2011-03-17       Impact factor: 7.446

5.  Discovery of a potent and efficacious peptide derivative for δ/μ opioid agonist/neurokinin 1 antagonist activity with a 2',6'-dimethyl-L-tyrosine: in vitro, in vivo, and NMR-based structural studies.

Authors:  Takashi Yamamoto; Padma Nair; Tally M Largent-Milnes; Neil E Jacobsen; Peg Davis; Shou-Wu Ma; Henry I Yamamura; Todd W Vanderah; Frank Porreca; Josephine Lai; Victor J Hruby
Journal:  J Med Chem       Date:  2011-03-02       Impact factor: 7.446

Review 6.  Design of peptide and peptidomimetic ligands with novel pharmacological activity profiles.

Authors:  Victor J Hruby; Minying Cai
Journal:  Annu Rev Pharmacol Toxicol       Date:  2013       Impact factor: 13.820

Review 7.  Design of novel melanocortin receptor ligands: multiple receptors, complex pharmacology, the challenge.

Authors:  Victor J Hruby; Minying Cai; James Cain; Joel Nyberg; Dev Trivedi
Journal:  Eur J Pharmacol       Date:  2011-01-03       Impact factor: 4.432

8.  Discovery of Novel Multifunctional Ligands with μ/δ Opioid Agonist/Neurokinin-1 (NK1) Antagonist Activities for the Treatment of Pain.

Authors:  Aswini Kumar Giri; Christopher R Apostol; Yue Wang; Brittany L Forte; Tally M Largent-Milnes; Peg Davis; David Rankin; Gabriella Molnar; Keith M Olson; Frank Porreca; Todd W Vanderah; Victor J Hruby
Journal:  J Med Chem       Date:  2015-10-30       Impact factor: 7.446

Review 9.  Investigational peptide and peptidomimetic μ and δ opioid receptor agonists in the relief of pain.

Authors:  Aswini Kumar Giri; Victor J Hruby
Journal:  Expert Opin Investig Drugs       Date:  2013-12-13       Impact factor: 6.206

10.  Discovery of tripeptide-derived multifunctional ligands possessing delta/mu opioid receptor agonist and neurokinin 1 receptor antagonist activities.

Authors:  Padma Nair; Takashi Yamamoto; Scott Cowell; Vinod Kulkarni; Sharif Moye; Edita Navratilova; Peg Davis; Shou-Wu Ma; Todd W Vanderah; Josephine Lai; Frank Porreca; Victor J Hruby
Journal:  Bioorg Med Chem Lett       Date:  2015-06-15       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.